<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article article-type="rapid-communication" dtd-version="1.0" specific-use="sps-1.8" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">rca</journal-id>
			<journal-title-group>
				<journal-title>Revista Colombiana de Anestesiología</journal-title>
				<abbrev-journal-title abbrev-type="publisher">Rev. colomb. anestesiol.</abbrev-journal-title>
			</journal-title-group>
			<issn pub-type="ppub">0120-3347</issn>
			<publisher>
				<publisher-name>SCARE-Sociedad Colombiana de Anestesiología y Reanimación</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.1097/CJ9.0000000000000011</article-id>
			<article-id pub-id-type="publisher-id">00011</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>BRIEF ACADEMY</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Comment about &quot;Hypertonic saline solution for modifying tissue ischemia/reperfusion injury: Porcine aortic occlusion model&quot;</article-title>
				<trans-title-group xml:lang="es">
					<trans-title>Comentario sobre &quot;Solución salina hipertónica para medicar la lesión tisular por isquemia/reperfusión: modelo porcino de oclusión de aorta&quot;</trans-title>
				</trans-title-group>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Cassinello Plaza</surname>
						<given-names>Fernando S.</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"><sup>a</sup></xref>
					<xref ref-type="corresp" rid="c1"><sup>*</sup></xref>
				</contrib>
				<aff id="aff1">
					<label>a</label>
					<institution content-type="original"> Nuestra Señora de Candelaria University Hospital, Santa Cruz de Tenerife, Spain</institution>
					<institution content-type="orgname">Nuestra Señora de Candelaria University Hospital</institution>
					<addr-line>
						<named-content content-type="city">Santa Cruz de Tenerife</named-content>
					</addr-line>
					<country country="ES">Spain</country>
				</aff>
			</contrib-group>
			<author-notes>
				<corresp id="c1">
					<label><sup>*</sup></label> Correspondence: Hospital Universitario Nuestra Señora de Candelaria, Carretera del Rosario 145, Santa Cruz de Tenerife, 38010 Tenerife, España. E-mail: <email>fcassinello@fjd.es</email>
				</corresp>
			</author-notes>
			<pub-date pub-type="epub-ppub">
				<season>Jan-Apr</season>
				<year>2018</year>
			</pub-date>
			<volume>46</volume>
			<issue>1</issue>
			<fpage>65</fpage>
			<lpage>67</lpage>
			<permissions>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" xml:lang="en">
					<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
				</license>
			</permissions>
			<counts>
				<fig-count count="0"/>
				<table-count count="0"/>
				<equation-count count="0"/>
				<ref-count count="22"/>
				<page-count count="3"/>
			</counts>
		</article-meta>
	</front>
	<body>
		<p>Escobar et al<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> published an original article evaluating the impact of a hypertonic saline solution (HSS) in an animal model of ischemia/reperfusion. The significance of this article is the experimental model that links basic research to the clinic, through an animal study stimulating a usual situation in vascular surgery, that is, aortic clamping.</p>
		<p>Several animal models or models on ischemia/reperfusion in organs such as the liver, the gut, or the heart have been published.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref> The model used by Garutti et al in lung surgery may serve as an example.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref>
		</p> <p>The purpose of this paper is to determine whether HSS reduces the ischemic/reperfusion injury in the liver, kidney, and ileum. To this end, 2 groups receiving HSS or physiological saline 15 minutes before aortic clamping were included. The authors justify the study based on endothelial damage and reperfusion-associated phenomena.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> Different papers have shown the benefit of reestablishing volemia in ischemia/reperfusion models, for instance in the lung, during coronary surgery, or at the renal level with different solutions such as HSS or starches.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
		</p> <p>The authors identified hemodynamic differences in the systolic index following perfusion, with rising systolic index in the SSH group as compared with the baseline, and decreasing levels among the control group. However, no differences were found in other renal or liver damage parameters, neither in the endothelin values. The creatinine values in the control group were actually higher at the end of the experiment, but these differences were not statistically significant. As mentioned during the discussion, probably no significant differences have been shown due to clamping time (15minutes), whether because of the HSS dose administered, or because of the time at which the 3 samples were collected. Hence, in a recently published study, doses similar to HSS have shown to reduce lung damage, in combination with valproate.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref> In terms of cerebral protection, several trials show the benefits of HSS, including a recent trial in children with severe head and neck trauma.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref>
		</p> <p>The authors do find differences in pH, which is somewhat higher with the administration of HSS; lactate values are lower in the HSS group. Differences were also found in the sodium and calcium values. The rise in calcium and sodium following HSS administration had been previously identified and is mentioned by the authors in this publication, referring to isolated cardiac muscle models where positive inotropic and lusitropic effects of HSS have also been shown, mediated by the hyperosmolality and the sodium action on the Na+ - Ca+2 exchanger, preserving the homeostasis of intracellular calcium and its release from the sarcoplasmic reticulum.<xref ref-type="bibr" rid="B4"><sup>4</sup></xref>
		</p> <p>What the authors fail to discuss is the potential deleterious effect of calcium in situations of reperfusion, as has been proven for instance in cardiac surgery.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> Deleterious effects have also been found with sodium and chlorine overload. Hyperchloremia as a result of excessive chlorine has been associated with increased mortality in the intensive care unit and in postsurgical patients, based on the amount of chlorine administered and the production of hyperchloremic acidosis.<xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref> Hypernatremia in critical care units is associated with too much salt administered and increased mortality.<xref ref-type="bibr" rid="B14"><sup>14</sup></xref> In this case, the dose administered does not increase the mean sodium values above the normal levels, but is something to keep in mind when transferring the HSS experience to the usual clinical practice. The chlorine values are not measured and hence we do not know its impact. It will be logical to think that they rise similarly to sodium levels in the group that received HSS, but do not know to what extent and whether the rise exceeded the normal limits.</p>
		<p>Restoring volemia with physiological saline occasionally leads to hyperchloremic acidosis; consequently, some authors recommend limiting the dose of the so-called &quot;physiological saline,&quot; particularly following resuscitation.<xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref>
		</p> <p>The use of colloids has not only failed to show any benefit, but may even be harmful. Starches increased mortality due to renal damage in critical patients, and particularly with SEPSIS.<xref ref-type="bibr" rid="B16"><sup>16</sup></xref> Albumin has also been associated with increased mortality in patients with severe head trauma.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref> Volume overload is also associated with increased mortality in critical patients.<xref ref-type="bibr" rid="B18"><sup>18</sup></xref> The need to undertake further studies comparing different solutions has encouraged different comparative essays using balanced saline solutions.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref>
		</p> <p>As mentioned by the authors, reactive oxygen species (ROS) may play a key role in the origin of the ischemia-reperfusion phenomenon, although this could be related with low antioxidant levels. This has been seen for instance in hepatic steatosis, which is associated with mitochondrial dysfunction and excessive mitochondrial ROS production.<xref ref-type="bibr" rid="B20"><sup>20</sup></xref>
		</p> <p>In sum, pretreatment with HSS in this experimental ischemia/reperfusion model in animals has shown hemodynamic value and has apparently improved perfusion, with enhanced lactate and pH control levels. No differences in terms of organ damage have yet been shown; however, a relatively short clamping time could be the cause for this lack of results. The experimental model is an example of basic methodology and enables damage assessment through serum and tissue samples. Regardless of the considerations and thoughts about salt overload, the decision to transfer this experience to the clinic is difficult because of the lack of evidence, and because of the difficult choice between less volume and more salt content and a major contribution of fluids that also entail morbidity, particularly affecting the lungs and the brain.</p>
		<p>The selected dose of HSS, 4 ml/kg at 7.5%, has been effective and is similar to that of other trials that did show organ protection<xref ref-type="bibr" rid="B21"><sup>21</sup></xref>; furthermore, the sodium values were within the normal range. The available clinical evidence on the use of HSS is limited and inconclusive for this indication, but it has proven to be effective in hemorrhagic shock and in some head and neck trauma studies. Clinical trials in the operating room have shown, similar to this study, a hemodynamic improvement, particularly in heart surgery.<xref ref-type="bibr" rid="B22"><sup>22</sup></xref> However, similar trials are needed in clinical practice, particularly in vascular surgery, comparing HSS to other solutions in terms of hemodynamics and tissue damage.</p>
		<p>Basic research, whether in vitro or in animals like in this case, is a cornerstone of medical practice, and we anesthesiologists should not neglect this fact. All anesthesia departments and universities are called upon to stimulate and facilitate basic research, as few areas of specialization require so much knowledge in basic sciences, and particularly of physiology and pharmacology. In addition to the stress situations associated with surgical aggression, the metabolic response triggered shall be controlled by the anesthesiologist. Experimental models that mimic everyday clinical situations such as the one herein depicted, promote an enhanced knowledge of the effects of anesthesia with regards to different treatments. Fluid therapy is not exempt from risks and fluids shall be subject to the same consideration as any other drug. Therefore, keeping a log of the dose administered and of any associated adverse events is mandatory and essential.</p>
		<sec>
			<title>Ethical disclosures</title>
			<p><bold>Protection of human and animal subjects.</bold> The authors declare that no experiments were performed on humans or animals for this study.</p>
			<p><bold>Confidentiality of data.</bold> The authors declare that they have followed the protocols of their work center on the publication of patient data.</p>
			<p><bold>Right to privacy and informed consent.</bold> The authors declare that no patient data appear in this article.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>References</title>
			<ref id="B1">
				<label>1</label>
				<mixed-citation>1. Escobar B, Guevara-Cruz OA, Navarro-Vargas JR, et al. Hypertonic saline solution for modifying tissue ischemia/reperfusion injury: Porcine aortic occlusion model. Rev Colomb Anestesiol 2017; 45:280-290.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Escobar</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Guevara-Cruz</surname>
							<given-names>OA</given-names>
						</name>
						<name>
							<surname>Navarro-Vargas</surname>
							<given-names>JR</given-names>
						</name>
					</person-group>
					<article-title>Hypertonic saline solution for modifying tissue ischemia/reperfusion injury Porcine aortic occlusion model</article-title>
					<source>Rev Colomb Anestesiol</source>
					<year>2017</year>
					<volume>45</volume>
					<fpage>280</fpage>
					<lpage>290</lpage>
				</element-citation>
			</ref>
			<ref id="B2">
				<label>2</label>
				<mixed-citation>2. Heino A, Hartikainen J, Merasto ME, et al. Effects of dobuta-mine on splanchnic tissue perfusion during partial superior mesenteric artery occlusion. Crit Care Med 2000;28:3484-3490.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Heino</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Hartikainen</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Merasto</surname>
							<given-names>ME</given-names>
						</name>
					</person-group>
					<article-title>Effects of dobuta-mine on splanchnic tissue perfusion during partial superior mesenteric artery occlusion</article-title>
					<source>Crit Care Med</source>
					<year>2000</year>
					<volume>28</volume>
					<fpage>3484</fpage>
					<lpage>3490</lpage>
				</element-citation>
			</ref>
			<ref id="B3">
				<label>3</label>
				<mixed-citation>3. Sidi A, Muehlschlegel JD, Kirby DS, et al. Treating ischemic left ventricular dysfunction with hypertonic saline administered after coronary occlusion in pigs. J Cardiothorac Vasc Anesth 2007; 21:400-405.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Sidi</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Muehlschlegel</surname>
							<given-names>JD</given-names>
						</name>
						<name>
							<surname>Kirby</surname>
							<given-names>DS</given-names>
						</name>
					</person-group>
					<article-title>Treating ischemic left ventricular dysfunction with hypertonic saline administered after coronary occlusion in pigs</article-title>
					<source>J Cardiothorac Vasc Anesth</source>
					<year>2007</year>
					<volume>21</volume>
					<fpage>400</fpage>
					<lpage>405</lpage>
				</element-citation>
			</ref>
			<ref id="B4">
				<label>4</label>
				<mixed-citation>4. Mouren S, Delayance S, Mion G, et al. Mechanisms of increased myocardial contractility with hypertonic saline solutions in isolated blood-perfused rabbit hearts. Anesth Analg 1995;81: 777-782.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mouren</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Delayance</surname>
							<given-names>S</given-names>
						</name>
						<name>
							<surname>Mion</surname>
							<given-names>G</given-names>
						</name>
					</person-group>
					<article-title>Mechanisms of increased myocardial contractility with hypertonic saline solutions in isolated blood-perfused rabbit hearts</article-title>
					<source>Anesth Analg</source>
					<year>1995</year>
					<volume>81</volume>
					<fpage>777</fpage>
					<lpage>782</lpage>
				</element-citation>
			</ref>
			<ref id="B5">
				<label>5</label>
				<mixed-citation>5. Huerta L, Rancan L, Simón C, et al. Ischaemic preconditioning prevents the liver inflammatory response to lung ischaemia/ reperfusion in a swine lung autotransplant model. Eur J Cardiothorac Surg 2013;43:1194-1201.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Huerta</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Rancan</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Simón</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Ischaemic preconditioning prevents the liver inflammatory response to lung ischaemia/ reperfusion in a swine lung autotransplant model</article-title>
					<source>Eur J Cardiothorac Surg</source>
					<year>2013</year>
					<volume>43</volume>
					<fpage>1194</fpage>
					<lpage>1201</lpage>
				</element-citation>
			</ref>
			<ref id="B6">
				<label>6</label>
				<mixed-citation>6. Li R, Zijlstra JG, Kamps JAAM, et al. Abrupt reflow enhances cytokine- induced proinflammatory activation of endothelial cells during simulated shock and resuscitation. Shock 2014; 42:356-364.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Li</surname>
							<given-names>R</given-names>
						</name>
						<name>
							<surname>Zijlstra</surname>
							<given-names>JG</given-names>
						</name>
						<name>
							<surname>Kamps</surname>
							<given-names>JAAM</given-names>
						</name>
					</person-group>
					<article-title>Abrupt reflow enhances cytokine- induced proinflammatory activation of endothelial cells during simulated shock and resuscitation</article-title>
					<source>Shock</source>
					<year>2014</year>
					<volume>42</volume>
					<fpage>356</fpage>
					<lpage>364</lpage>
				</element-citation>
			</ref>
			<ref id="B7">
				<label>7</label>
				<mixed-citation>7. Lomivorotov VV, Fominskiy EV, Efremov SM, et al. Hypertonic solution decreases extravascular lung water in cardiac patients undergoing cardiopulmonary bypass surgery. J Cardiothorac Vasc Anesth 2013;27:273-282.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lomivorotov</surname>
							<given-names>VV</given-names>
						</name>
						<name>
							<surname>Fominskiy</surname>
							<given-names>EV</given-names>
						</name>
						<name>
							<surname>Efremov</surname>
							<given-names>SM</given-names>
						</name>
					</person-group>
					<article-title>Hypertonic solution decreases extravascular lung water in cardiac patients undergoing cardiopulmonary bypass surgery</article-title>
					<source>J Cardiothorac Vasc Anesth</source>
					<year>2013</year>
					<volume>27</volume>
					<fpage>273</fpage>
					<lpage>282</lpage>
				</element-citation>
			</ref>
			<ref id="B8">
				<label>8</label>
				<mixed-citation>8. Oliveira-santos M, Lopes MF, Catré D, et al. Efeito de hidrox-ietilamido sobre lesão renal aguda em modelo de isquemia-reperfusão hepática. Acta Med Port 2012;25:308-316.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Oliveira-santos</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Lopes</surname>
							<given-names>MF</given-names>
						</name>
						<name>
							<surname>Catré</surname>
							<given-names>D</given-names>
						</name>
					</person-group>
					<article-title>Efeito de hidrox-ietilamido sobre lesão renal aguda em modelo de isquemia-reperfusão hepática</article-title>
					<source>Acta Med Port</source>
					<year>2012</year>
					<volume>25</volume>
					<fpage>308</fpage>
					<lpage>316</lpage>
				</element-citation>
			</ref>
			<ref id="B9">
				<label>9</label>
				<mixed-citation>9. Nikolian VC, Pan B, Mesar T, et al. Lung protective effects of low-volume resuscitation and pharmacologic treatment of swine subjected to polytrauma and hemorrhagic shock. Inflammation 2017;40:1264-1274.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Nikolian</surname>
							<given-names>VC</given-names>
						</name>
						<name>
							<surname>Pan</surname>
							<given-names>B</given-names>
						</name>
						<name>
							<surname>Mesar</surname>
							<given-names>T</given-names>
						</name>
					</person-group>
					<article-title>Lung protective effects of low-volume resuscitation and pharmacologic treatment of swine subjected to polytrauma and hemorrhagic shock</article-title>
					<source>Inflammation</source>
					<year>2017</year>
					<volume>40</volume>
					<fpage>1264</fpage>
					<lpage>1274</lpage>
				</element-citation>
			</ref>
			<ref id="B10">
				<label>10</label>
				<mixed-citation>10. Rallis D, Poulos P, Kazantzi M, et al. Effectiveness of 7.5% hypertonic saline in children with severe traumatic brain injury. J Crit Care 2017;38:52-56.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Rallis</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Poulos</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Kazantzi</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Effectiveness of 7 5% hypertonic saline in children with severe traumatic brain injury</article-title>
					<source>J Crit Care</source>
					<year>2017</year>
					<volume>38</volume>
					<fpage>52</fpage>
					<lpage>56</lpage>
				</element-citation>
			</ref>
			<ref id="B11">
				<label>11</label>
				<mixed-citation>11. Opie LH. Point of view reperfusion injury and its pharmacologic modification. Circulation 1989;80:1049-1062.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Opie</surname>
							<given-names>LH</given-names>
						</name>
					</person-group>
					<article-title>Point of view reperfusion injury and its pharmacologic modification</article-title>
					<source>Circulation</source>
					<year>1989</year>
					<volume>80</volume>
					<fpage>1049</fpage>
					<lpage>1062</lpage>
				</element-citation>
			</ref>
			<ref id="B12">
				<label>12</label>
				<mixed-citation>12. Shaw AD, Munson SH, Paluszkiewicz SM, et al. Association between intravenous chloride load during resuscitation and inhospital mortality among patients with SIRS. Intensive Care Med 2014;40:1897-1905.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Shaw</surname>
							<given-names>AD</given-names>
						</name>
						<name>
							<surname>Munson</surname>
							<given-names>SH</given-names>
						</name>
						<name>
							<surname>Paluszkiewicz</surname>
							<given-names>SM</given-names>
						</name>
					</person-group>
					<article-title>Association between intravenous chloride load during resuscitation and inhospital mortality among patients with SIRS</article-title>
					<source>Intensive Care Med</source>
					<year>2014</year>
					<volume>40</volume>
					<fpage>1897</fpage>
					<lpage>1905</lpage>
				</element-citation>
			</ref>
			<ref id="B13">
				<label>13</label>
				<mixed-citation>13. Boniatti M, Cardoso P, Castilho R, et al. Is hyperchloremia associated with mortality in critically ill patients? A prospective cohort study. J Crit Care 2011;26:175-179.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Boniatti</surname>
							<given-names>M</given-names>
						</name>
						<name>
							<surname>Cardoso</surname>
							<given-names>P</given-names>
						</name>
						<name>
							<surname>Castilho</surname>
							<given-names>R</given-names>
						</name>
					</person-group>
					<article-title>Is hyperchloremia associated with mortality in critically ill patients A prospective cohort study</article-title>
					<source>J Crit Care</source>
					<year>2011</year>
					<volume>26</volume>
					<fpage>175</fpage>
					<lpage>179</lpage>
				</element-citation>
			</ref>
			<ref id="B14">
				<label>14</label>
				<mixed-citation>14. Lindner G, Funk GC, Schwarz C, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis 2007;50:952-957.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Lindner</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Funk</surname>
							<given-names>GC</given-names>
						</name>
						<name>
							<surname>Schwarz</surname>
							<given-names>C</given-names>
						</name>
					</person-group>
					<article-title>Hypernatremia in the critically ill is an independent risk factor for mortality</article-title>
					<source>Am J Kidney Dis</source>
					<year>2007</year>
					<volume>50</volume>
					<fpage>952</fpage>
					<lpage>957</lpage>
				</element-citation>
			</ref>
			<ref id="B15">
				<label>15</label>
				<mixed-citation>15. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013;369:1243-1251.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Myburgh</surname>
							<given-names>JA</given-names>
						</name>
						<name>
							<surname>Mythen</surname>
							<given-names>MG</given-names>
						</name>
					</person-group>
					<article-title>Resuscitation fluids</article-title>
					<source>N Engl J Med</source>
					<year>2013</year>
					<volume>369</volume>
					<fpage>1243</fpage>
					<lpage>1251</lpage>
				</element-citation>
			</ref>
			<ref id="B16">
				<label>16</label>
				<mixed-citation>16. Perners A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus ringer&amp;apos;s acetate in severe sepsis. N Engl J Med 2012;367:124-134.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Perners</surname>
							<given-names>A</given-names>
						</name>
						<name>
							<surname>Haase</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Guttormsen</surname>
							<given-names>AB</given-names>
						</name>
					</person-group>
					<article-title>Hydroxyethyl starch 130/0 42 versus ringer&amp;apos;s acetate in severe sepsis</article-title>
					<source>N Engl J Med</source>
					<year>2012</year>
					<volume>367</volume>
					<fpage>124</fpage>
					<lpage>134</lpage>
				</element-citation>
			</ref>
			<ref id="B17">
				<label>17</label>
				<mixed-citation>17. Cooper D, Myburgh J, Heritier S, et al. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma 2013;30:512-518.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Cooper</surname>
							<given-names>D</given-names>
						</name>
						<name>
							<surname>Myburgh</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Heritier</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>Albumin resuscitation for traumatic brain injury is intracranial hypertension the cause of increased mortality?</article-title>
					<source>J Neurotrauma</source>
					<year>2013</year>
					<volume>30</volume>
					<fpage>512</fpage>
					<lpage>518</lpage>
				</element-citation>
			</ref>
			<ref id="B18">
				<label>18</label>
				<mixed-citation>18. Wang N, Jiang L, Zhu B, et al. Fluid balance and mortality in critically ill patients with acute kidney injury: a multicenter prospective epidemiological study. Crit Care 2015;19:1-11.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Wang</surname>
							<given-names>N</given-names>
						</name>
						<name>
							<surname>Jiang</surname>
							<given-names>L</given-names>
						</name>
						<name>
							<surname>Zhu</surname>
							<given-names>B</given-names>
						</name>
					</person-group>
					<article-title>Fluid balance and mortality in critically ill patients with acute kidney injury a multicenter prospective epidemiological study</article-title>
					<source>Crit Care</source>
					<year>2015</year>
					<volume>19</volume>
					<fpage>1</fpage>
					<lpage>11</lpage>
				</element-citation>
			</ref>
			<ref id="B19">
				<label>19</label>
				<mixed-citation>19. Semler MW, Self WH, Wang L, et al. Balanced crystalloids versus saline in the intensive care unit: study protocol for a cluster-randomized, multiple-crossover trial. Trials 2017;18:1-13.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Semler</surname>
							<given-names>MW</given-names>
						</name>
						<name>
							<surname>Self</surname>
							<given-names>WH</given-names>
						</name>
						<name>
							<surname>Wang</surname>
							<given-names>L</given-names>
						</name>
					</person-group>
					<article-title>Balanced crystalloids versus saline in the intensive care unit study protocol for a cluster-randomized, multiple-crossover trial</article-title>
					<source>Trials</source>
					<year>2017</year>
					<volume>18</volume>
					<fpage>1</fpage>
					<lpage>13</lpage>
				</element-citation>
			</ref>
			<ref id="B20">
				<label>20</label>
				<mixed-citation>20. Prieto I, Monsalve M. Redox Biology ROS homeostasis, a key determinant in liver ischemic-preconditioning. Redox Biol 2017;12:1020-1025.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Prieto</surname>
							<given-names>I</given-names>
						</name>
						<name>
							<surname>Monsalve</surname>
							<given-names>M</given-names>
						</name>
					</person-group>
					<article-title>Redox Biology ROS homeostasis, a key determinant in liver ischemic-preconditioning</article-title>
					<source>Redox Biol</source>
					<year>2017</year>
					<volume>12</volume>
					<fpage>1020</fpage>
					<lpage>1025</lpage>
				</element-citation>
			</ref>
			<ref id="B21">
				<label>21</label>
				<mixed-citation>21. Shields CJ, Winter DC, Manning BJ, et al. Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion. Arch Surg 2003;138:9-14.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Shields</surname>
							<given-names>CJ</given-names>
						</name>
						<name>
							<surname>Winter</surname>
							<given-names>DC</given-names>
						</name>
						<name>
							<surname>Manning</surname>
							<given-names>BJ</given-names>
						</name>
					</person-group>
					<article-title>Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion</article-title>
					<source>Arch Surg</source>
					<year>2003</year>
					<volume>138</volume>
					<fpage>9</fpage>
					<lpage>14</lpage>
				</element-citation>
			</ref>
			<ref id="B22">
				<label>22</label>
				<mixed-citation>22. Azoubel G, Nascimento IB, Ferri IIM, et al. Operating room use of hypertonic solutions: a clinical review. Clinics 2008;63:833-840.</mixed-citation>
				<element-citation publication-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Azoubel</surname>
							<given-names>G</given-names>
						</name>
						<name>
							<surname>Nascimento</surname>
							<given-names>IB</given-names>
						</name>
						<name>
							<surname>Ferri</surname>
							<given-names>IIM</given-names>
						</name>
					</person-group>
					<article-title>Operating room use of hypertonic solutions a clinical review</article-title>
					<source>Clinics</source>
					<year>2008</year>
					<volume>63</volume>
					<fpage>833</fpage>
					<lpage>840</lpage>
				</element-citation>
			</ref>
		</ref-list>
		<fn-group>
			<fn fn-type="other" id="fn1">
				<label>How to cite this article:</label>
				<p> Cassinello Plaza FS. Comment about &quot;Hypertonic saline solution for modifying tissue ischemia/reperfusion injury: Porcine aortic occlusion model&quot;. Rev Colomb Anestesiol. 2018;46:65-67.</p>
			</fn>
			<fn fn-type="other" id="fn2">
				<label>Funding</label>
				<p> Author was not sponsored to carry out this article.</p>
			</fn>
			<fn fn-type="other" id="fn3">
				<label>3</label>
				<p><bold>Conflicts of interest</bold> Author declares having no conflict of interest to disclose.</p>
			</fn>
		</fn-group>
	</back>
	<!--sub-article article-type="translation" id="s1" xml:lang="es">
		<front-stub>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>BREVES DE LA ACADEMIA</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Comentario sobre &quot;Solución salina hipertónica para medicar la lesión tisular por isquemia/reperfusión: modelo porcino de oclusión de aorta&quot;</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Cassinello Plaza</surname>
						<given-names>Fernando S.</given-names>
					</name>
					<xref ref-type="aff" rid="aff2"><sup>a</sup></xref>
					<xref ref-type="corresp" rid="c2"><sup>*</sup></xref>
				</contrib>
				<aff id="aff2">
					<label>a </label>
					<institution content-type="original">Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España</institution>
					<institution content-type="orgname">Hospital Universitario Nuestra Señora de Candelaria</institution>
					<addr-line>
						<named-content content-type="city">Santa Cruz de Tenerife</named-content>
					</addr-line>
					<country country="ES">España</country>
				</aff>
			</contrib-group>
			<author-notes>
				<corresp id="c2">
					<label><sup>*</sup></label> Correspondencia: Carretera del Rosario 145, Santa Cruz de Tenerife, 38010. Tenerife, España. Correo electrónico: <email>fcassinello@fjd.es</email>
				</corresp>
			</author-notes>
		</front-stub>
		<body>
			<p>Escobar y cois.<xref ref-type="bibr" rid="B1"><sup>1</sup></xref> publican un artículo original que evalúa el impacto de una solución salina hipertónica (SSH) en un modelo animal de isquemia/reperfusión. El mérito principal de este artículo es el modelo experimental, que relaciona la investigación básica con la clínica a través de un estudio en animales que simula una situación habitual en la cirugía vascular, como es el clampeo aórtico.</p>
			<p>Se han publicado diferentes modelos animales o sobre tejido asilado de isquemia/reperfusión en órganos como el hígado, intestino o miocardio.<xref ref-type="bibr" rid="B2"><sup>2</sup></xref><sup>-</sup><xref ref-type="bibr" rid="B4"><sup>4</sup></xref> Sirva como ejemplo de modelo el utilizado por Garutti y cols. en cirugía pulmonar.<xref ref-type="bibr" rid="B5"><sup>5</sup></xref>
			</p> <p>Este trabajo plantea como objetivo determinar si la SSH disminuye la lesión isquemia/reperfusión en hígado, riñón e íleon. Para ello se incluyen dos grupos a los que se administra SSH o suero fisiológico como pre-tratamiento al clampeo aórtico de 15 minutos. Los autores justifican el estudio en el daño endotelialy los fenómenos asociados a la reperfusión.<xref ref-type="bibr" rid="B6"><sup>6</sup></xref> Diferentes trabajos han demostrado el beneficio de reponer la volemia en modelos de isquemia/reperfusión, como por ejemplo en pulmón durante la cirugía coronaria o a nivel renal con diferentes soluciones como el SSH o los almidones.<xref ref-type="bibr" rid="B7"><sup>7</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B8"><sup>8</sup></xref>
			</p> <p>Los autores en este caso encuentran diferencias hemodinámicas tras la reperfusión en el índice sistólico que aumenta en el grupo SSH respecto al basal y disminuye en el grupo control. Sin embargo, no encuentran diferencias en otros parámetros de daño renal o hepático, ni en los valores de endotelina. Es cierto que los valores de creatinina en el grupo control son mayores al final del experimento pero no alcanzan la significación estadística. Probablemente no han conseguido demostrar diferencias significativas por el tiempo de clampeo (15 minutos), tal y como se apunta en la discusión, o bien por la dosis administrada de SSH, o por el momento de toma de las muestras. Así, dosis similares de SSH han demostrado reducir el daño pulmonar en combinación con valproato en un estudio publicado recientemente.<xref ref-type="bibr" rid="B9"><sup>9</sup></xref> En el caso de la protección cerebral diversos estudios muestran beneficios del SSH, incluido uno reciente en niños con traumatismo craneoencefálico severo.<xref ref-type="bibr" rid="B10"><sup>10</sup></xref>
			</p> <p>Los autores sí encuentran diferencias en el pH, que es algo mayor con la administración del SSH, así como en los valores de lactato, inferiores en el grupo de SSH. También se evidencian diferencias en los valores de sodio y calcio. Este incremento de calcio y sodio tras la administración de SSH ya era conocido previamente y es citado por los autores en esta publicación, refiriéndose a modelos de musculo cardiaco aislado en los que se han demostrado también los efectos inotrópico y lusitrópico positivos de la SSH, mediados por la hiperosmolaridad y la acción del sodio sobre el intercambiador Na+- Ca+2, manteniendo la homeostasis del calcio intracelular y su salida del retículo sarcoplásmico.<xref ref-type="bibr" rid="B4"><sup>4</sup></xref>
			</p> <p>Lo que no discuten los autores es el posible efecto deletéreo del calcio en situaciones de reperfusión, tal y como se ha demostrado por ejemplo en cirugía cardiaca.<xref ref-type="bibr" rid="B11"><sup>11</sup></xref> En cuanto a la sobrecarga de sodio y cloro, también se ha visto que puede tener efectos nocivos. La hipercloremia por exceso de administración de Cloro se ha asociado un aumento de mortalidad en Unidades de Cuidados Intensivos y en pacientes postquirurgicos, en relación con el total de cloro administrado y la producción de acidosis hiperclorémica.<xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B13"><sup>13</sup></xref> La hipernatremia en las unidades de críticos se relaciona con el exceso de sal administrado y se asocia a un aumento de mortalidad.<xref ref-type="bibr" rid="B14"><sup>14</sup></xref> En este caso la dosis administrada no incrementa los valores medios de sodio por encima de los valores normales, pero es algo a tener en cuenta a la hora de trasladar la experiencia del SSH a la práctica clínica habitual. No se miden los valores de cloro, por lo que no sabemos el impacto. Sería lógico pensar que aumentan al igual que el sodio en el grupo que recibió SSH, pero no sabemos cuánto, ni si ha sido por encima de los límites normales.</p>
			<p>La reposición de la volemia con suero fisiológico provoca en ocasiones acidosis hiperclórémica, motivo por el que algunos autores recomiendan limitar la dosis del &quot;mal llamado&quot; suero fisiológico, sobre todo después de la resucitación.<xref ref-type="bibr" rid="B12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="B15"><sup>15</sup></xref>
			</p> <p>El uso de coloides no solo no ha demostrado beneficios, sino que además puede provocar daño. Los almidones aumentaron la mortalidad por daño renal en pacientes críticos y en especial con SEPSIS.<xref ref-type="bibr" rid="B16"><sup>16</sup></xref> La albumina también se ha asociado con un aumento de mortalidad en pacientes con traumatismo craneal grave.<xref ref-type="bibr" rid="B17"><sup>17</sup></xref> La sobrecarga de volumen también se asocia a un aumento de la mortalidad en pacientes críticos.<xref ref-type="bibr" rid="B18"><sup>18</sup></xref> La necesidad de estudios que comparen diferentes soluciones ha estimulado el inicio de diferentes ensayos comparativos utilizando sueros balanceados.<xref ref-type="bibr" rid="B19"><sup>19</sup></xref>
			</p> <p>Como bien indican los autores las especies reactivas de oxígeno (ROS) pueden jugar un papel principal en la génesis de los fenómenos de isquemia-repefusión, aunque podrían estar relacionados con unos niveles bajos de antioxidantes. Esto se ha visto, por ejemplo, en la esteatosis hepática, la cual está relacionada con la disfunción mitocondrial y la producción excesiva de ROS por la mitocondria.<xref ref-type="bibr" rid="B20"><sup>20</sup></xref>
			</p> <p>En resumen, el pre-tratamiento con SSH en este modelo experimental en animales de isquemia/reperfusión, ha demostrado una utilidad hemodinámica y ha mejorado aparentemente la perfusión controlando mejor los niveles de lactato y el pH. No se han podido demostrar diferencias en daño orgánico, pero un tiempo de clampeo relativamente corto podría serla causa de esta falta de resultados. El modelo experimental es un ejemplo de metodología básica y permite la valoración del daño mediante muestras séricas y de tejido. Independientemente de las consideraciones y reflexiones sobre la sobrecarga de sal, la decisión de trasladar esta experiencia a la clínica, es compleja por la falta de evidencias y por la difícil decisión entre menor volumen y más contenido de sal y un mayor aporte de líquidos, que tiene también su morbilidad, especialmente a nivel pulmonar y cerebral.</p>
			<p>La dosis de SSH elegida, 4ml/kg al 7,5%, ha sido eficaz y es similar a la de otros estudios que si mostraron protección orgánica,<xref ref-type="bibr" rid="B21"><sup>21</sup></xref> y los valores de sodio se mantuvieron dentro de la normalidad. La evidencia clínica disponible sobre el uso de SSH es limitada y poco concluyente en esta indicación, pero si se ha demostrado utilidad en el shock hemorrágico y en algunos estudios de traumatismo craneoencefálico. Los estudios clínicos en quirófano muestran, al igual que este estudio, una mejora hemodinámica sobre todo en cirugía cardiaca.<xref ref-type="bibr" rid="B22"><sup>22</sup></xref> A pesar de ello hacen falta ensayos similares a los de este trabajo en la práctica clínica y en particular en cirugía vascular que comparen el SSH con otras soluciones en términos hemodinámicos y de daño tisular.</p>
			<p>La investigación básica, in vitro o en animales como en este caso, es un pilar fundamental de la actividad médica y los anestesiólogos no debemos olvidar esta faceta. Desde los servicios de anestesia y las universidades se debe estimular y facilitar la investigación básica pues pocas especialidades requieren tanto conocimiento de las ciencias básicas y en especial de la fisiología y la farmacología. Además las situaciones de estrés relacionadas con la agresión quirúrgica generan una respuesta metabólica que el anestesiólogo debe controlar. Modelos experimentales que emulen situaciones clínicas habituales como el referido en este estudio facilitan un mayor conocimiento de los efectos de la anestesia en relación con diferentes tratamientos. La fluidoterapia no está exenta de riesgos y los fluidos deben tener la misma consideración que cualquier otro fármaco. Por ello el registro de la dosis administrada y de los eventos adversos relacionados es obligado y fundamental.</p>
			<sec>
				<title>Responsabilidades éticas</title>
				<p><bold>Protección de personas y animals.</bold> Los autores declaran que para esta investigación no se han realizado experimentos en seres humanos ni en animales.</p>
				<p><bold>Confidencialidad de los datos.</bold> Los autores declaran que han seguido los protocolos de su centro de trabajo sobre la publicación de datos de pacientes.</p>
				<p><bold>Derecho a la privacidad y consentimiento informado.</bold></p>
				<p>Los autores declaran que en este artículo no aparecen datos de pacientes.</p>
			</sec>
			<sec>
				<title>Financiamiento</title>
				<p>El autor no recibió patrocinio para llevar a cabo este artículo.</p>
			</sec>
			<sec>
				<title>Conflicto de intereses</title>
				<p>El autor declara no tener conflicto de intereses.</p>
			</sec>
		</body>
		<back>
			<fn-group>
				<fn fn-type="other" id="fn4">
					<label>Cómo citar este artículo:</label>
					<p> Cassinello Plaza FS. Comentario sobre &quot;Solución salina hipertónica para modificar la lesión tisular por isquemia/reperfusión: modelo porcino de oclusión de aorta&quot;. Rev Colomb Anestesiol. 2018;46:68-70.</p>
				</fn>
			</fn-group>
		</back>
	</sub-article-->
</article>